Terms: = Liver cancer AND NSD1, FLJ44628, 64324, ENSG00000165671, Q96L73, FLJ22263, DKFZp666C163, ARA267, STO, SOTOS
13 results:
1. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.
Chen Y; Tang W; Zhu X; Zhang L; Zhu Y; Xiao H; Xu J; Fang Y; Li X; Tang C; Shi J
Bioengineered; 2021 Dec; 12(2):11506-11519. PubMed ID: 34905470
[TBL] [Abstract] [Full Text] [Related]
3. Role of nsd1 as potential therapeutic target in tumor.
Yang C; Wang K; Liang Q; Tian TT; Zhong Z
Pharmacol Res; 2021 Nov; 173():105888. PubMed ID: 34536546
[TBL] [Abstract] [Full Text] [Related]
4. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis reveals distinct mutational signature and its mechanistic insights of alcohol consumption in human cancers.
Wei R; Li P; He F; Wei G; Zhou Z; Su Z; Ni T
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32480415
[TBL] [Abstract] [Full Text] [Related]
6. CRISPR/Cas9-mediated knockout of nsd1 suppresses the hepatocellular carcinoma development via the nsd1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract] [Full Text] [Related]
7. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
8. Pharmacological inhibition of CaMKK2 with the selective antagonist sto-609 regresses NAFLD.
York B; Li F; Lin F; Marcelo KL; Mao J; Dean A; Gonzales N; Gooden D; Maity S; Coarfa C; Putluri N; Means AR
Sci Rep; 2017 Sep; 7(1):11793. PubMed ID: 28924233
[TBL] [Abstract] [Full Text] [Related]
9. The camKK2/camKIV relay is an essential regulator of hepatic cancer.
Lin F; Marcelo KL; Rajapakshe K; Coarfa C; Dean A; Wilganowski N; Robinson H; Sevick E; Bissig KD; Goldie LC; Means AR; York B
Hepatology; 2015 Aug; 62(2):505-20. PubMed ID: 25847065
[TBL] [Abstract] [Full Text] [Related]
10. The role of genetics in the establishment and maintenance of the epigenome.
Huidobro C; Fernandez AF; Fraga MF
Cell Mol Life Sci; 2013 May; 70(9):1543-73. PubMed ID: 23474979
[TBL] [Abstract] [Full Text] [Related]
11. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.
Tong X; Smith KA; Pelling JC
Mol Carcinog; 2012 Mar; 51(3):268-79. PubMed ID: 21538580
[TBL] [Abstract] [Full Text] [Related]
12. Hepatoblastoma in a patient with sotos syndrome.
Kato M; Takita J; Takahashi K; Mimaki M; Chen Y; Koh K; Ida K; Oka A; Mizuguchi M; Ogawa S; Igarashi T
J Pediatr; 2009 Dec; 155(6):937-9. PubMed ID: 19914434
[TBL] [Abstract] [Full Text] [Related]
13. A case of cerebral gigantism and hepatocarcinoma.
Sugarman GI; Heuser ET; Reed WB
Am J Dis Child; 1977 Jun; 131(6):631-3. PubMed ID: 194475
[TBL] [Abstract] [Full Text] [Related]
